KalVista Pharmaceuticals, Inc.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US4834971032

USD

16.46

-0.14 (-0.84%)

Mar 24

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Arbutus Biopharma Corp.

SIGA Technologies, Inc.

Liquidia Corp.

Nurix Therapeutics, Inc.

Marinus Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

Coherus BioSciences, Inc.

Oric Pharmaceuticals, Inc.

Cullinan Therapeutics, Inc.

KalVista Pharmaceuticals, Inc.

Icosavax, Inc.

Why is KalVista Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is KalVista Pharmaceuticals, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

KalVista Pharmaceuticals, Inc.

34.37%

0.60

63.15%

S&P 500

13.68%

0.84

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

22.87%

EBIT Growth (5y)

-216.56%

EBIT to Interest (avg)

-87.67

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.18

Sales to Capital Employed (avg)

0.03

Tax Ratio

1.88%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

50.01

EV to EBIT

-4.01

EV to EBITDA

-4.03

EV to Capital Employed

-43.54

EV to Sales

53.88

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-1227.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

ROCE(HY)

Highest at 0%

DEBT-EQUITY RATIO (HY)

Lowest at -156.36 %

RAW MATERIAL COST(Y)

Fallen by -9,100% (YoY

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for KalVista Pharmaceuticals, Inc.

Debt-Equity Ratio

Lowest at -156.36 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -9,100% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales